A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2522649A1 Treatment of conditions involving amyloid plaques
11/04/2004	CA2522581A1 A seeded tear resistant scaffold
11/04/2004	CA2522560A1 Antisense modulation of apolipoprotein c-iii expression
11/04/2004	CA2522364A1 Polymer-conjugated glycosylated neublastin
11/04/2004	CA2522362A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	CA2521847A1 Use of b7-h3 as an immunoregulatory agent
11/04/2004	CA2521210A1 Methods for monitoring drug activities in vivo
11/04/2004	CA2520886A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/04/2004	CA2520655A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	CA2520097A1 Truncated baff receptors
11/04/2004	CA2519563A1 Cytokine-expressing cellular vaccine combinations
11/04/2004	CA2519338A1 Antineoplastic combinations
11/04/2004	CA2518336A1 Polyethelene glycol link glp-1 compounds
11/03/2004	EP1473366A1 Keratinocyte growth factor-2 products
11/03/2004	EP1473365A1 Angiogenesis inhibitors
11/03/2004	EP1473304A1 Method for preparation of a N-terminally modified chemotactic factor
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473302A1 HETEROCYCLIC COMPOUNDS HAVING ELASTASE−INHIBITING ACTIVITY AND INTERMEDIATES THEREOF
11/03/2004	EP1473041A2 Anti-allergic pharmaceutical composition
11/03/2004	EP1473040A1 Use of human parathyroid hormone
11/03/2004	EP1473039A1 Use of inhibitors and antisense oligonucleotides of BTK for the treatment of proliferative mastocytosis
11/03/2004	EP1473037A1 Treatment of hPMV infections with Ribavirin
11/03/2004	EP1473034A1 Use of an inhibitor of the phosphodiesterase-4-enzyme (PDE4) alone or in combination with relaxin and derivatives thereof for the manufacture of a medicament to promote decidualization of endometrial cells and to increase fertility
11/03/2004	EP1473029A1 Solid dosage form comprising desmopressin
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472376A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
11/03/2004	EP1472375A1 Gene products differentially expressed in cancerous breast cells and their methods of use
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472345A2 Metalloproteins
11/03/2004	EP1472344A2 Novel protein
11/03/2004	EP1472290A2 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof
11/03/2004	EP1472288A2 Viral cd30 polypeptide
11/03/2004	EP1472287A1 Rhamnose binding protein
11/03/2004	EP1472282A2 Use of calmodulin to promote bone regeneration
11/03/2004	EP1472280A2 Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472278A2 Macrocyclic peptides active against the hepatitis c virus
11/03/2004	EP1472277A1 Fap-activated anti-tumor compounds
11/03/2004	EP1472276A2 Small peptides capable of modulating the function of cd66 (ceacam) family members
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472266A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
11/03/2004	EP1472265A2 Rna interference mediated inhibition of polycomb group protein ezh2 gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1471974A1 Tumor necrosis factor combined with interferon in demyelinating diseases
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471944A2 Pharmaceutical composition which improves in vivo gene transfer
11/03/2004	EP1471942A1 Immunocytokine-containing lyophilized preparation
11/03/2004	EP1471941A1 Method of treatment of vulval vestibulitis
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1471935A2 Protease screening and novel use of proteases
11/03/2004	EP1471934A2 Kinases involved in the regulation of energy homeostasis
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471932A1 Use of a polypeptide for treatment of pruritus in animals
11/03/2004	EP1471931A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/03/2004	EP1471930A1 Use of erythropoietin for the preventive or curative treatment of cardiac failure
11/03/2004	EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471903A2 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
11/03/2004	EP1471891A2 Polymer-based compositions for sustained release
11/03/2004	EP1471871A2 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1206257B1 Use of amino acids for making medicines for treating insulin-resistance
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1165111A4 Method for pr-39 peptide regulated stimulation of angiogenesis
11/03/2004	EP1094831A4 Compositions and methods for in vitro fertilization
11/03/2004	EP1082436B1 Moraxella catarrhalis pilq proteins
11/03/2004	EP1071400B1 Drug delivery of proteins from polymeric blends
11/03/2004	EP1068155A4 Substrate for array printing
11/03/2004	EP1047709B1 Compounds with growth hormone releasing properties
11/03/2004	EP0971686B1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
11/03/2004	EP0927023B1 Composition for treating acne
11/03/2004	EP0896625B1 Recombinant ribonuclease proteins
11/03/2004	EP0729325B1 Osteogenic product and use
11/03/2004	EP0722324B1 Pharmaceutical composition for immunoenhancement therapy
11/03/2004	EP0694042B1 Inhibitor of vascular endothelial cell growth factor
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543503A Metalloproteinase inhibitors for wound healing
11/03/2004	CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
11/03/2004	CN1543476A Methods and compounds for the targeting of protein to exosomes
11/03/2004	CN1543475A Novel genetic products from ashbya gossypii, associated withthe structure of the cell wall or the cytoskeleton
11/03/2004	CN1543357A 5-CNAC as oral delivery agent for parathyroid hormone fragments
11/03/2004	CN1543354A Botulinum toxin in the treatment or prevention of acne
11/03/2004	CN1543349A Enhanced drug delivery in transdermal systems

1 ... 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 ... 3163